Cargando…
Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti- versus Pro-Tumoral Activities
Vγ9Vδ2-T cells are considered as potent effector cells for tumor immunotherapy through directly killing tumor cells and indirectly regulating other innate and adaptive immune cells to establish antitumoral immunity. The antitumoral activity of Vγ9Vδ2-T cells is governed by a complicated set of activ...
Autores principales: | Xiang, Zheng, Tu, Wenwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581348/ https://www.ncbi.nlm.nih.gov/pubmed/28894450 http://dx.doi.org/10.3389/fimmu.2017.01041 |
Ejemplares similares
-
CD137 Costimulation Enhances the Antitumor Activity of Vγ9Vδ2-T Cells in IL-10-Mediated Immunosuppressive Tumor Microenvironment
por: Pei, Yujun, et al.
Publicado: (2022) -
Human Vγ9Vδ2-T Cells Synergize CD4(+) T Follicular Helper Cells to Produce Influenza Virus-Specific Antibody
por: Chen, Qingyun, et al.
Publicado: (2018) -
Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells
por: Joalland, Noémie, et al.
Publicado: (2020) -
Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens
por: Holmen Olofsson, Gitte, et al.
Publicado: (2021) -
Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells
por: Gu, Siyi, et al.
Publicado: (2015)